GDRX (GoodRx Holdings) Moat Score: 6/10 (As of Jul. 03, 2026)


GDRX GoodRx Holdings Inc GDRX
65 GF Score
Price $3.05
GF Value $5.66
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is GoodRx Holdings Moat Score?

GoodRx Holdings GDRX -0.33% 65 Moat Score is 6 as of Jul. 03, 2026. GuruFocus rates GDRX with a GF Score™ of 65/100 and a GF Value™ of $5.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 679 Healthcare Providers & Services companies, GoodRx Holdings ranks better than 99.12% on this metric.

GoodRx Holdings has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

GoodRx Holdings has Narrow Moat: GoodRx Holdings Inc has a strong narrow moat due to its robust network effects and brand strength in the digital healthcare space. Its platform offers significant customer value, but competition and regulatory risks prevent a wide moat classification.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes GoodRx Holdings might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

GoodRx Holdings  (NAS:GDRX) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

GoodRx Holdings Moat Score Related Terms

GDRX vs CERT, TALK, HSTM: Moat Score Comparison

For the Health Information Services subindustry, GoodRx Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GoodRx Holdings Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where GoodRx Holdings's Moat Score falls into.


GDRX
65GF Score
GoodRx Holdings Inc GDRX
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
GoodRx Holdings (GDRX) has a Moat Score of 6 as of Jul. 03, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, GoodRx Holdings ranks #6 out of 679 companies in the Healthcare Providers & Services industry, placing it in the top 0.90000000000001%.
Is GoodRx Holdings' Moat Score too high?
GoodRx Holdings' current Moat Score is 6. Based on the distribution chart, GoodRx Holdings ranks #6 out of 679 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, GoodRx Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoodRx Holdings' Moat Score compare to CERT and TALK?
According to the Healthcare Providers & Services industry distribution chart, GoodRx Holdings ranks #6 out of 679 companies for Moat Score. This places GoodRx Holdings in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. GoodRx Holdings's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoodRx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.66, compared to a current price of $3.05 — trading 46.1% below its estimated fair value. The current Moat Score is 6. GoodRx Holdings' overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current Moat Score is 6 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GoodRx Holdings (GDRX) Overvalued in 2026?

Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued. The current stock price of $3.05 is trading 46.1% below its estimated GF Value™ of $5.66. GuruFocus considers GoodRx Holdings to be Possible Value Trap.

Key valuation signals for GDRX:

  • Moat Score: 6
  • GF Value™: $5.66 vs. price of $3.05 (46.1% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GoodRx Holdings Business Description

Other Exchanges 8GH:Germany
Address 2701 Olympic Boulevard, Santa Monica, CA, USA, 90404
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
65GF Score

Get the complete analysis for GDRX

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.05
Price
$5.66
GF Value